CompletedNot applicableNCT05326503

Inhibitory Effect of a Polyphenol Supplement on Dietary Iron Absorption in Adults with Thalassemia

Studying Dietary iron overload disease

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Swiss Federal Institute of Technology
Principal Investigator: Michael B Zimmermann, MD, PhD
ETH Zurich
Intervention: Meal matrix with polyphenol supplement (PPS)(dietary_supplement)
Enrollment: 20 enrolled
Eligibility: 18-49 years · All sexes
Timeline: 2022 – 2023

Study locations (1)

Mahidol University, Salaya, Thailand

Collaborators

Mahidol University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05326503 on ClinicalTrials.gov

Other trials for Dietary iron overload disease

Additional recruiting or active studies for the same condition.

RECRUITINGNCT07028112
Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.
Assistance Publique - Hôpitaux de Paris

See all trials for Dietary iron overload disease →

← Back to all trials